Phibro Animal Health Corporation Company Profile (NASDAQ:PAHC)

About Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health Corporation logoPhibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Veterinary Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PAHC
  • CUSIP: N/A
  • Web: www.pahc.com
Capitalization:
  • Market Cap: $1.5301 billion
  • Outstanding Shares: 39,641,000
Average Prices:
  • 50 Day Moving Avg: $36.94
  • 200 Day Moving Avg: $31.35
  • 52 Week Range: $19.02 - $39.00
P/E:
  • Trailing P/E Ratio: 23.98
  • Foreward P/E Ratio: 24.65
  • P/E Growth: 5.71
Sales & Book Value:
  • Annual Revenue: $758.62 million
  • Price / Sales: 2.01
  • Book Value: $3.52 per share
  • Price / Book: 10.92
Dividend:
  • Annual Dividend: $0.40
  • Dividend Yield: 1.0%
Profitability:
  • EBIDTA: $116.09 million
  • Net Margins: 8.49%
  • Return on Equity: 54.68%
  • Return on Assets: 10.12%
Debt:
  • Debt-to-Equity Ratio: 2.20%
  • Current Ratio: 3.27%
  • Quick Ratio: 1.73%
Misc:
  • Average Volume: 151,027 shs.
  • Beta: 1.35
  • Short Ratio: 1.64
 
Frequently Asked Questions for Phibro Animal Health Corporation (NASDAQ:PAHC)

What is Phibro Animal Health Corporation's stock symbol?

Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?

Phibro Animal Health Corporation announced a quarterly dividend on Tuesday, July 25th. Stockholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share on Wednesday, September 27th. This represents a $0.40 annualized dividend and a dividend yield of 1.04%. The ex-dividend date is Friday, September 1st. View Phibro Animal Health Corporation's Dividend History.

How were Phibro Animal Health Corporation's earnings last quarter?

Phibro Animal Health Corporation (NASDAQ:PAHC) announced its quarterly earnings data on Monday, May, 8th. The company reported $0.37 EPS for the quarter, meeting the Zacks' consensus estimate of $0.37. The firm earned $190 million during the quarter, compared to analysts' expectations of $185.90 million. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. Phibro Animal Health Corporation's revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 EPS. View Phibro Animal Health Corporation's Earnings History.

When will Phibro Animal Health Corporation make its next earnings announcement?

Phibro Animal Health Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, August, 30th 2017. View Earnings Estimates for Phibro Animal Health Corporation.

What guidance has Phibro Animal Health Corporation issued on next quarter's earnings?

Phibro Animal Health Corporation updated its FY17 earnings guidance on Monday, May, 8th. The company provided earnings per share (EPS) guidance of $1.44-1.47 for the period, compared to the Thomson Reuters consensus estimate of $1.43. The company issued revenue guidance of $760-765 million, compared to the consensus revenue estimate of $757.20 million.

Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?

6 brokers have issued 1 year price objectives for Phibro Animal Health Corporation's stock. Their forecasts range from $21.00 to $36.00. On average, they anticipate Phibro Animal Health Corporation's share price to reach $29.00 in the next year. View Analyst Ratings for Phibro Animal Health Corporation.

What are analysts saying about Phibro Animal Health Corporation stock?

Here are some recent quotes from research analysts about Phibro Animal Health Corporation stock:

  • 1. According to Zacks Investment Research, "Phibro ended third-quarter fiscal 2017 on a sluggish note, with earnings in line with the Zacks Consensus Estimate and declining year over year. Notably, the stock was trading below the Zacks categorized Medical Information Systems industry over the last three months. However post the earnings release the company’s share price shot up. This may be on account Phibro’s revenues increase on a year-over-year basis with Animal Health remaining the key contributing business. The company’s strong operating margin is also encouraging. Improved full-year earnings guidance is an upside too. On the flip side, additionally, currency fluctuations, sluggish macro-economic conditions and a tough competitive scenario are major concerns of the company. This fails to boost market confidence on the stock." (5/11/2017)
  • 2. Piper Jaffray Companies analysts commented, "We continue to favor shares of PAHC as a top small cap idea in our ag space, where we see potential for upward revisions to guidance in 2H17 following the 2Q earnings beat and management reaffirming guidance. Positively, the Animal Health segment grew in the December-ending quarter despite ongoing headwinds in MFAs, supporting our thesis around the resilience of the animal health industry. We are lifting our FY17 EPS estimate to $1.45 at the top of the guidance range and we see potential earnings upside in 2H17 from growth outside of MFAs and in other geographies like Brazil. We see multiple expansion opportunity with some of the MFA overhang on the stock removed after the resilient 2Q results and our price target moves to $34 based on 21X FY18E EPS of $1.60. We reiterate our Overweight rating." (2/8/2017)

Who are some of Phibro Animal Health Corporation's key competitors?

Who owns Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include BFI COMPANY ., LLC (51.80%), Spark Investment Management LLC (0.41%), Acadian Asset Management LLC (0.33%), Sit Investment Associates Inc. (0.38%), Bank of Montreal Can (0.14%) and Russell Investments Group Ltd. (0.10%). Company insiders that own Phibro Animal Health Corporation stock include Bfi Co, Llc, Daniel A Welch, Dean J Warras, E Thomas Corcoran, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger. View Institutional Ownership Trends for Phibro Animal Health Corporation.

Who sold Phibro Animal Health Corporation stock? Who is selling Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Spark Investment Management LLC, OLD National Bancorp IN and Sit Investment Associates Inc.. Company insiders that have sold Phibro Animal Health Corporation stock in the last year include Bfi Co, Llc, Daniel A Welch, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger. View Insider Buying and Selling for Phibro Animal Health Corporation.

Who bought Phibro Animal Health Corporation stock? Who is buying Phibro Animal Health Corporation stock?

Phibro Animal Health Corporation's stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Strs Ohio, First Quadrant L P CA, Russell Investments Group Ltd., Bank of Montreal Can, Eqis Capital Management Inc., Campbell & CO Investment Adviser LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Phibro Animal Health Corporation.

How do I buy Phibro Animal Health Corporation stock?

Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Phibro Animal Health Corporation's stock price today?

One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $38.45.


MarketBeat Community Rating for Phibro Animal Health Corporation (NASDAQ PAHC)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  188
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Phibro Animal Health Corporation (NASDAQ:PAHC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $29.00 (24.58% downside)

Analysts' Ratings History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Piper Jaffray CompaniesSet Price TargetBuy$35.00LowView Rating Details
6/2/2017Credit Suisse GroupDowngradeOutperform -> Neutral$29.00 -> $36.00HighView Rating Details
11/11/2016MacquarieDowngradeNeutral -> Underperform$21.00N/AView Rating Details
11/10/2016GabelliDowngradeBuy -> HoldN/AView Rating Details
9/12/2016GuggenheimSet Price TargetBuy$26.00 -> $30.00N/AView Rating Details
9/4/2016Morgan StanleySet Price TargetSell$23.00N/AView Rating Details
1/15/2016Barclays PLCDowngradeOverweight -> Underweight$36.00 -> $31.00N/AView Rating Details
(Data available from 7/28/2015 forward)

Earnings

Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Earnings by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)
Earnings History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/30/2017$0.36N/AView Earnings Details
5/8/2017Q3 2017$0.37$0.37$185.90 million$190.00 millionViewListenView Earnings Details
2/6/2017Q217$0.35$0.39$194.16 million$192.00 millionViewListenView Earnings Details
11/9/2016Q1 2017$0.34$0.36$188.85 million$188.00 millionViewListenView Earnings Details
8/29/2016Q416$0.38$0.40$189.20 millionViewN/AView Earnings Details
5/9/2016Q316$0.43$0.38$197.24 million$183.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.41$0.39$198.27 million$191.80 millionViewN/AView Earnings Details
11/9/2015Q1$0.41$0.44$192.28 million$187.10 millionViewN/AView Earnings Details
9/9/2015Q415$0.38$0.44$185.00 millionViewN/AView Earnings Details
5/11/2015Q315$0.36$0.41$187.80 million$187.50 millionViewN/AView Earnings Details
2/10/2015Q215$0.36$0.35$181.52 million$188.70 millionViewN/AView Earnings Details
11/11/2014Q115$0.35$0.51$174.90 million$187.50 millionViewN/AView Earnings Details
9/16/2014Q414$0.27$0.22$175.90 million$183.70 millionViewN/AView Earnings Details
5/13/2014Q314$0.14$0.21$162.70 million$173.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Phibro Animal Health Corporation (NASDAQ:PAHC)
Current Year EPS Consensus Estimate: $1.45 EPS
Next Year EPS Consensus Estimate: $1.56 EPS

Dividends

Current Dividend Information for Phibro Animal Health Corporation (NASDAQ:PAHC)
Next Dividend:9/27/2017
Annual Dividend:$0.40
Dividend Yield:1.04%
Payout Ratio:24.69% (Trailing 12 Months of Earnings)
27.59% (Based on This Year's Estimates)
25.64% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Dividend History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/25/2017quarterly$0.101.04%9/1/20179/6/20179/27/2017
5/9/2017Quarterly$0.101.2%5/26/20175/31/20176/22/2017
2/7/2017quarterly$0.101.37%2/27/20173/1/20173/22/2017
11/8/2016quarterly$0.101.51%11/28/201611/30/201612/21/2016
7/26/2016quarterly$0.101.95%9/2/20169/7/20169/28/2016
5/10/2016quarterly$0.102.17%5/27/20166/1/20166/22/2016
2/9/2016quarterly$0.101.18%2/29/20163/2/20163/23/2016
11/10/2015quarterly$0.101.26%11/30/201512/2/201512/23/2015
7/28/2015quarterly$0.101.08%8/31/20159/2/20159/23/2015
5/12/2015quarterly$0.101.09%6/1/20156/3/20156/24/2015
2/10/2015quarterly$0.101.43%3/2/20153/4/20153/25/2015
11/10/2014quarterly$0.101.43%12/1/201412/3/201412/23/2014
7/28/2014quarterly$0.108/29/20149/3/20149/24/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Insider Ownership Percentage: 48.09%
Institutional Ownership Percentage: 47.21%
Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)
Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)
Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/6/2017Bfi Co., LlcMajor ShareholderSell16,000$36.00$576,000.00View SEC Filing  
7/6/2017Jack BendheimInsiderSell32,000$36.49$1,167,680.00View SEC Filing  
7/5/2017Bfi Co., LlcMajor ShareholderSell16,000$36.98$591,680.00View SEC Filing  
6/30/2017Bfi Co., LlcMajor ShareholderSell48,000$37.42$1,796,160.00View SEC Filing  
6/23/2017Jack BendheimInsiderSell48,000$37.15$1,783,200.00View SEC Filing  
6/15/2017Bfi Co., LlcMajor ShareholderSell48,000$34.82$1,671,360.00View SEC Filing  
6/9/2017Jack BendheimInsiderSell48,000$35.62$1,709,760.00View SEC Filing  
5/25/2017Jack BendheimInsiderSell48,000$34.67$1,664,160.00View SEC Filing  
5/19/2017Jack BendheimInsiderSell48,000$34.15$1,639,200.00View SEC Filing  
5/11/2017Gerald K CarlsonDirectorSell63,338$33.31$2,109,788.78View SEC Filing  
5/10/2017Jack BendheimInsiderSell1,400$34.04$47,656.00View SEC Filing  
5/9/2017Larry Lee MillerCOOSell56,825$30.95$1,758,733.75View SEC Filing  
5/9/2017Thomas G DaggerSVPSell8,000$32.13$257,040.00View SEC Filing  
5/4/2017Larry Lee MillerCOOSell18,953$30.13$571,053.89View SEC Filing  
5/1/2017Larry Lee MillerCOOSell14,780$30.13$445,321.40View SEC Filing  
3/20/2017Gerald K CarlsonDirectorSell12,000$28.13$337,560.00View SEC Filing  
2/27/2017Gerald K CarlsonDirectorSell12,000$28.29$339,480.00View SEC Filing  
2/16/2017Daniel A WelchSVPSell5,000$29.55$147,750.00View SEC Filing  
2/16/2017Larry Lee MillerCOOSell4,588$30.00$137,640.00View SEC Filing  
2/15/2017Gerald K CarlsonDirectorSell12,000$29.77$357,240.00View SEC Filing  
2/13/2017Larry Lee MillerCOOSell97,229$30.37$2,952,844.73View SEC Filing  
1/4/2017Thomas G DaggerSVPSell207$30.00$6,210.00View SEC Filing  
1/3/2017Larry Lee MillerCOOSell187$30.00$5,610.00View SEC Filing  
12/20/2016Larry Lee MillerCOOSell1,540$30.04$46,261.60View SEC Filing  
12/20/2016Thomas G DaggerSVPSell1,700$30.03$51,051.00View SEC Filing  
12/19/2016Larry Lee MillerCOOSell252$30.00$7,560.00View SEC Filing  
12/19/2016Thomas G DaggerSVPSell200$30.01$6,002.00View SEC Filing  
5/19/2016E Thomas CorcoranDirectorBuy5,000$18.14$90,700.00View SEC Filing  
4/1/2016Gerald K CarlsonCOOSell8,000$27.02$216,160.00View SEC Filing  
2/19/2016Gerald K CarlsonCOOSell8,000$28.09$224,720.00View SEC Filing  
2/17/2016Bfi Co., LlcMajor ShareholderSell2,175$30.01$65,271.75View SEC Filing  
2/10/2016Bfi Co., Llcmajor shareholderSell3,400$30.78$104,652.00View SEC Filing  
2/3/2016Bfi Co., Llcmajor shareholderSell4,000$33.26$133,040.00View SEC Filing  
2/3/2016Jack BendheimCEOSell12,000$33.39$400,680.00View SEC Filing  
2/2/2016Bfi Co., Llcmajor shareholderSell4,000$33.44$133,760.00View SEC Filing  
2/1/2016Bfi Co., Llcmajor shareholderSell4,000$33.46$133,840.00View SEC Filing  
2/1/2016Larry Lee MillerPresidentSell60,000$33.58$2,014,800.00View SEC Filing  
1/29/2016Jack BendheimCEOSell39,944$32.10$1,282,202.40View SEC Filing  
1/26/2016Daniel A. WelchSVPSell3,000$32.05$96,150.00View SEC Filing  
1/26/2016Gerald K. CarlsonCOOSell12,923$32.13$415,215.99View SEC Filing  
1/22/2016Larry Lee MillerPresidentSell51,225$30.07$1,540,335.75View SEC Filing  
1/20/2016Gerald K. CarlsonCOOSell8,000$29.27$234,160.00View SEC Filing  
1/8/2016Larry Lee MillerPresidentSell4,303$30.03$129,219.09View SEC Filing  
1/6/2016Bfi Co., Llcmajor shareholderSell3,005$29.93$89,939.65View SEC Filing  
1/6/2016Jack BendheimCEOSell8,056$30.01$241,760.56View SEC Filing  
1/6/2016Larry Lee MillerPresidentSell4,472$30.10$134,607.20View SEC Filing  
1/5/2016Bfi Co., Llcmajor shareholderSell4,851$30.07$145,869.57View SEC Filing  
1/4/2016Bfi Co., Llcmajor shareholderSell200$29.92$5,984.00View SEC Filing  
12/30/2015Bfi Co., Llcmajor shareholderSell4,000$30.63$122,520.00View SEC Filing  
12/30/2015Jack BendheimCEOSell12,000$30.49$365,880.00View SEC Filing  
12/29/2015Bfi Co., Llcmajor shareholderSell4,000$30.49$121,960.00View SEC Filing  
12/28/2015Bfi Co., Llcmajor shareholderSell4,000$30.34$121,360.00View SEC Filing  
12/23/2015Gerald K. CarlsonCOOSell2,006$32.03$64,252.18View SEC Filing  
12/22/2015Gerald K. CarlsonCOOSell1,071$32.02$34,293.42View SEC Filing  
12/21/2015Gerald K. CarlsonCOOSell8,000$31.13$249,040.00View SEC Filing  
12/18/2015Jack BendheimCEOSell12,000$31.83$381,960.00View SEC Filing  
12/15/2015Larry Lee MillerinsiderSell36,090$31.00$1,118,790.00View SEC Filing  
12/14/2015Larry Lee MillerinsiderSell23,910$30.74$734,993.40View SEC Filing  
12/11/2015Jack BendheimCEOSell12,000$31.58$378,960.00View SEC Filing  
12/3/2015Jack BendheimCEOSell12,000$32.63$391,560.00View SEC Filing  
11/24/2015Gerald K. CarlsonCOOSell16,000$32.08$513,280.00View SEC Filing  
11/24/2015Thomas G. DaggerSVPSell4,000$32.87$131,480.00View SEC Filing  
11/18/2015Bfi Co., Llcmajor shareholderSell4,000$31.68$126,720.00View SEC Filing  
11/18/2015Jack BendheimCEOSell12,000$31.63$379,560.00View SEC Filing  
11/17/2015Bfi Co., Llcmajor shareholderSell4,000$31.71$126,840.00View SEC Filing  
11/16/2015Bfi Co., Llcmajor shareholderSell4,000$31.50$126,000.00View SEC Filing  
11/12/2015Bfi Co., Llcmajor shareholderSell12,000$32.21$386,520.00View SEC Filing  
11/5/2015Jack BendheimCEOSell12,000$33.11$397,320.00View SEC Filing  
10/30/2015Jack BendheimCEOSell12,000$33.21$398,520.00View SEC Filing  
10/26/2015Gerald K. CarlsonCOOSell7,900$32.15$253,985.00View SEC Filing  
10/26/2015Jack BendheimCEOSell12,000$31.73$380,760.00View SEC Filing  
10/21/2015Gerald K. CarlsonCOOSell8,100$32.40$262,440.00View SEC Filing  
10/16/2015Daniel A. WelchSVPSell3,000$32.93$98,790.00View SEC Filing  
10/16/2015Jack BendheimCEOSell12,000$32.10$385,200.00View SEC Filing  
10/9/2015Jack BendheimCEOSell12,000$30.64$367,680.00View SEC Filing  
10/1/2015Jack BendheimCEOSell12,000$31.44$377,280.00View SEC Filing  
9/25/2015Jack BendheimCEOSell10,000$33.95$339,500.00View SEC Filing  
9/23/2015Thomas G. DaggerSVPSell4,000$34.76$139,040.00View SEC Filing  
9/22/2015Gerald K. CarlsonCOOSell8,000$34.97$279,760.00View SEC Filing  
9/21/2015Gerald K. CarlsonCOOSell8,000$35.99$287,920.00View SEC Filing  
9/18/2015Jack BendheimCEOSell18,000$35.90$646,200.00View SEC Filing  
9/16/2015Dean J. WarrasinsiderSell4,000$34.73$138,920.00View SEC Filing  
9/10/2015Jack BendheimCEOSell18,000$34.69$624,420.00View SEC Filing  
9/3/2015Bfi Co., Llcmajor shareholderSell16,900$35.08$592,852.00View SEC Filing  
9/3/2015Jack BendheimCEOSell1,100$35.10$38,610.00View SEC Filing  
8/28/2015Jack BendheimCEOSell18,000$34.89$628,020.00View SEC Filing  
8/21/2015Gerald K. CarlsonCOOSell16,000$35.04$560,640.00View SEC Filing  
8/19/2015Bfi Co., LlcMajor ShareholderSell6,000$36.91$221,460.00View SEC Filing  
8/19/2015Jack BendheimCEOSell18,000$37.14$668,520.00View SEC Filing  
8/18/2015Bfi Co., LlcMajor ShareholderSell6,000$37.76$226,560.00View SEC Filing  
8/17/2015Bfi Co., LlcMajor ShareholderSell6,000$36.76$220,560.00View SEC Filing  
7/24/2015Jack BendheimCEOSell18,000$37.98$683,640.00View SEC Filing  
7/21/2015Gerald K CarlsonCOOSell8,000$37.97$303,760.00View SEC Filing  
7/20/2015Gerald K CarlsonCOOSell8,000$38.16$305,280.00View SEC Filing  
7/15/2015Bfi Co., LlcMajor ShareholderSell18,000$38.13$686,340.00View SEC Filing  
7/15/2015Jack BendheimCEOSell6,000$37.75$226,500.00View SEC Filing  
7/14/2015Jack BendheimCEOSell6,000$38.25$229,500.00View SEC Filing  
7/13/2015Jack BendheimCEOSell6,000$38.41$230,460.00View SEC Filing  
7/9/2015Jack BendheimCEOSell18,000$36.90$664,200.00View SEC Filing  
7/2/2015Bfi Co., LlcMajor ShareholderSell19,000$38.02$722,380.00View SEC Filing  
6/26/2015Jack BendheimCEOSell36,000$36.37$1,309,320.00View SEC Filing  
6/23/2015Gerald K CarlsonCOOSell16,000$36.56$584,960.00View SEC Filing  
6/22/2015Gerald K CarlsonCOOSell8,000$36.47$291,760.00View SEC Filing  
6/17/2015Bfi Co., LlcMajor ShareholderSell4,000$34.09$136,360.00View SEC Filing  
6/17/2015Jack BendheimCEOSell12,000$33.13$397,560.00View SEC Filing  
6/16/2015Bfi Co., LlcMajor ShareholderSell4,000$33.00$132,000.00View SEC Filing  
6/15/2015Bfi Co., LlcMajor ShareholderSell4,000$32.31$129,240.00View SEC Filing  
6/11/2015Jack BendheimCEOSell12,000$32.38$388,560.00View SEC Filing  
6/4/2015Jack BendheimCEOSell12,000$33.68$404,160.00View SEC Filing  
5/28/2015Bfi Co., LlcMajor ShareholderSell18,000$35.11$631,980.00View SEC Filing  
5/21/2015Gerald K CarlsonCOOSell16,000$35.62$569,920.00View SEC Filing  
5/19/2015Bfi Co., LlcMajor ShareholderSell18,000$36.73$661,140.00View SEC Filing  
5/18/2015Thomas G DaggerSVPSell4,000$36.48$145,920.00View SEC Filing  
12/19/2014Daniel A WelchSVPSell4,000$29.20$116,800.00View SEC Filing  
8/1/2014Bfi Co., LlcMajor ShareholderSell223,075$20.51$4,575,268.25View SEC Filing  
4/22/2014E Thomas CorcoranDirectorBuy5,000$16.70$83,500.00View SEC Filing  
4/16/2014Carol WrennDirectorBuy1,000$16.19$16,190.00View SEC Filing  
4/16/2014L.P. MayflowerMajor ShareholderSell6,323,867$13.99$88,470,899.33View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Phibro Animal Health Corporation (NASDAQ:PAHC)
Latest Headlines for Phibro Animal Health Corporation (NASDAQ:PAHC)
Source:
DateHeadline
americanbankingnews.com logoPhibro Animal Health Corporation (NASDAQ:PAHC) Declares $0.10 Quarterly Dividend
www.americanbankingnews.com - July 25 at 4:47 PM
americanbankingnews.com logo Brokerages Expect Phibro Animal Health Corporation (PAHC) to Announce $0.36 EPS
www.americanbankingnews.com - July 21 at 10:18 PM
americanbankingnews.com logoPhibro Animal Health Corporation (NASDAQ:PAHC) Stock Rating Reaffirmed by Piper Jaffray Companies
www.americanbankingnews.com - July 21 at 9:14 PM
americanbankingnews.com logoAnalyzing Phibro Animal Health Corporation (NASDAQ:PAHC) & Zoetis (ZTS)
www.americanbankingnews.com - July 12 at 8:18 AM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 11 at 12:20 AM
americanbankingnews.com logoInsider Selling: Phibro Animal Health Corporation (PAHC) Major Shareholder Sells 16,000 Shares of Stock
www.americanbankingnews.com - July 7 at 10:43 PM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Major Shareholder Sells $576,000.00 in Stock
www.americanbankingnews.com - July 7 at 10:43 PM
americanbankingnews.com logoJack Bendheim Sells 32,000 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) Stock
www.americanbankingnews.com - July 7 at 10:42 PM
finance.yahoo.com logoPhibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2017 Results
finance.yahoo.com - July 7 at 7:59 AM
finance.yahoo.com logoPhibro Animal Health & Zydus Cadila Plan to Expand in India
finance.yahoo.com - July 7 at 7:59 AM
streetinsider.com logoPhibro Animal Health (PAHC) & Zydus Cadila to License Poultry Vaccine Technology
www.streetinsider.com - July 6 at 7:49 AM
finance.yahoo.com logoPhibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro’s Poultry Vaccine Technologies
finance.yahoo.com - July 5 at 9:26 AM
americanbankingnews.com logoBfi Co., Llc Sells 48,000 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) Stock
www.americanbankingnews.com - June 30 at 10:30 PM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) vs. Zoetis (ZTS) Head to Head Survey
www.americanbankingnews.com - June 30 at 9:09 AM
americanbankingnews.com logoZacks: Analysts Anticipate Phibro Animal Health Corporation (PAHC) Will Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - June 27 at 6:20 PM
americanbankingnews.com logoInsider Selling: Phibro Animal Health Corporation (PAHC) Insider Sells 48,000 Shares of Stock
www.americanbankingnews.com - June 23 at 10:34 PM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Rating Increased to Strong-Buy at BidaskClub
www.americanbankingnews.com - June 22 at 6:04 PM
thestreet.com logoHow To YieldBoost Phibro Animal Health Corp. From 1.1% To 11.5% Using Options
www.thestreet.com - June 21 at 1:27 AM
finance.yahoo.com logoETFs with exposure to Phibro Animal Health Corp. : June 19, 2017
finance.yahoo.com - June 19 at 7:48 PM
finance.yahoo.com logoHealth Care Battle Rages On: 2 MedTech Stocks to Buy
finance.yahoo.com - June 16 at 8:40 AM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Major Shareholder Bfi Co., Llc Sells 48,000 Shares
www.americanbankingnews.com - June 15 at 10:26 PM
americanbankingnews.com logoFinancial Comparison: Zoetis (ZTS) and Phibro Animal Health Corporation (PAHC)
www.americanbankingnews.com - June 15 at 10:17 AM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Lowered to Buy at BidaskClub
www.americanbankingnews.com - June 14 at 5:58 PM
americanbankingnews.com logoPhibro Animal Health Corporation (PAHC) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - June 14 at 12:46 AM
finance.yahoo.com logoPhibro Animal Health (PAHC) Rides High on Solid Prospects
finance.yahoo.com - June 13 at 10:32 AM
finance.yahoo.com logoPhibro Animal Health (PAHC) Up 10% Since Earnings Report: Can It Continue?
finance.yahoo.com - June 12 at 6:47 PM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Insider Sells $1,709,760.00 in Stock
www.americanbankingnews.com - June 9 at 10:08 PM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Stock Rating Lowered by Credit Suisse Group AG
www.americanbankingnews.com - June 2 at 11:58 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Expected to Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - June 1 at 4:22 PM
finance.yahoo.com logoPhibro Animal Health Corp. : PAHC-US: Dividend Analysis : May 31st, 2017 (record date) : By the numbers : May 29, 2017
finance.yahoo.com - May 29 at 6:08 PM
americanbankingnews.com logoInsider Selling: Phibro Animal Health Corp (PAHC) Insider Sells 48,000 Shares of Stock
www.americanbankingnews.com - May 25 at 10:21 PM
seekingalpha.com logoPhibro Animal Health (PAHC) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 24 at 7:20 PM
americanbankingnews.com logoPhibro Animal Health Corp Declares Quarterly Dividend of $0.10 (pahc)
www.americanbankingnews.com - May 21 at 11:50 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 20 at 12:12 AM
finance.yahoo.com logoETFs with exposure to Phibro Animal Health Corp. : May 16, 2017
finance.yahoo.com - May 16 at 6:50 PM
finance.yahoo.com logoPhibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q3, 2017 By the Numbers : May 15, 2017
finance.yahoo.com - May 15 at 6:23 PM
finance.yahoo.com logoEdited Transcript of PAHC earnings conference call or presentation 9-May-17 1:00pm GMT
finance.yahoo.com - May 14 at 10:49 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Insider Jack Bendheim Sells 1,400 Shares
www.americanbankingnews.com - May 12 at 10:50 PM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Director Gerald K. Carlson Sells 63,338 Shares
www.americanbankingnews.com - May 12 at 10:16 AM
finance.yahoo.com logoCan The Uptrend Continue for Phibro Animal Health (PAHC)?
finance.yahoo.com - May 12 at 8:24 AM
seekingalpha.com logoPhibro Animal Health Corporation 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 12 at 12:36 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) SVP Thomas G. Dagger Sells 8,000 Shares
www.americanbankingnews.com - May 11 at 10:29 PM
americanbankingnews.com logoZacks Investment Research Upgrades Phibro Animal Health Corp (PAHC) to "Buy"
www.americanbankingnews.com - May 11 at 11:56 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) COO Sells $1,758,733.75 in Stock
www.americanbankingnews.com - May 9 at 10:21 PM
seekingalpha.com logoPhibro Animal Health's (PAHC) CEO Jack Bendheim on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 6:43 PM
streetinsider.com logoPhibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.3% Yield
www.streetinsider.com - May 9 at 11:15 AM
globenewswire.com logoPhibro Animal Health Corporation Reports Third Quarter
globenewswire.com - May 9 at 11:15 AM
finance.yahoo.com logoInvestor Network: Phibro Animal Health Corporation to Host Earnings Call
finance.yahoo.com - May 9 at 11:15 AM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Issues Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - May 8 at 9:24 PM
americanbankingnews.com logoPhibro Animal Health Corp (PAHC) Issues FY17 Earnings Guidance
www.americanbankingnews.com - May 8 at 5:26 PM

Social

Chart

Phibro Animal Health Corporation (PAHC) Chart for Friday, July, 28, 2017

This page was last updated on 7/28/2017 by MarketBeat.com Staff